Healthcare is a defensive sector with strong long-term growth drivers like demographics, innovation, and rising healthcare spending. I rate XLV a buy due to its diversified exposure across healthcare ...
IHE invests in large-cap U.S. pharmaceutical stocks with solid long-term growth outlook but high concentration risk. IHE's fund price has been steady with a positive trend in 2024, but its elevated ...
In trading on Thursday, shares of the iShares U.S. Pharmaceuticals ETF (Symbol: IHE) crossed above their 200 day moving average of $67.88, changing hands as high as $68.20 per share. iShares U.S.
Hosted on MSN
Pharma ETF (IHE) Hit a 52-Week High
Investors seeking momentum may have iShares U.S. Pharmaceuticals ETF IHE on radar now. The fund recently hit a new 52-week high. Shares of IHE are up approximately 29.6% from their 52-week low of ...
If you're interested in broad exposure to the Healthcare - Pharma segment of the equity market, look no further than the iShares U.S. Pharmaceuticals ETF (IHE), a passively managed exchange traded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results